# Oramed Pharmaceuticals Inc.: Form DEF 14A, filed Jun 2, 2022

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: DEF 14A
- Filed: 2022-06-02
- Accepted by EDGAR: Jun 2, 2022, 16:30 ET
- Period: 2022-06-30
- Accession: 0001213900-22-030956
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390022030956/ea160778-def14a_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390022030956/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390022030956/ea160778-def14a_oramed.htm

Filed Jun 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-030956. Last ingested by Listed: Nov 15, 2026, 04:14 ET. No prices; not investment advice.
